Zdrowie i gospodarka · 10/12/1998

FDA Reopens Comment Period for Human Cellular and Tissue-Based Products Establishment Registration and Listing Rule

The Food and Drug Administration (FDA) is reopening the comment period for a proposed rule on establishment registration and listing for manufacturers of human cellular and tissue-based products, originally published on May 14, 1998, in response to a request for an extension and to provide additional time for review and comment submission.